Structure and regulation of soluble guanylate cyclase
This work was supported by the Wilmot Cancer Institute Predoctoral Fellowship (to G.A.), the American Association for Cancer Research and Breast Cancer Research Foundation (20-20-26-HARR to I.S.H.), the Breast Cancer Coalition of Rochester (to I.S.H.), the American Cancer Society (RSG-23-971782-01-TBE to I.S.H.), the Ludwig Center for Metastasis Research (to A.M.), the University of Chicago Comprehensive Cancer Center (to A.M.), the Cancer Research Foundation (to A.M.), the V Foundation (to A.M.), the Pancreatic Cancer Action Network (to G.C.), the Lung Cancer Research Foundation (to J.C.), and NIH grants R01CA269813 (to I.S.H.), R01CA269813-S1 (to M.Z.), R37CA230042 (to G.M.D.), R24AA022057 (to V.V.), R01AA028859 (to Y.C.), R01CA276461 (to A.M.), T32CA009594 and F31CA278362 (to C.S.), and AI150698 (to J.M.)
These observations have contributed to ongoing research interest in the compounds potential interactions with vascular endothelial growth factor pathways
59.00 Natroceutics Glutathione SOD Advanced Liposomal Glutathione & protected superoxide dismutase
Aging-Related rotator cuff tears: molecular mechanisms and implications for clinical management
